Anti-Human TGFB2 Recombinant Antibody
-
产品编号
YR1117
-
别名
科研级 Lerdelimumab ( 乐德木单抗 ), Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Lerdelimumab ( 乐德木单抗 ), Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab |
| Catalog Number | YR1117 |
| Molecular Name | Lerdelimumab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG4 |
| Formulation | PBS, pH7.5 |
| Background | Lerdelimumab (CAT-152, intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug targeting TGF beta 2. It was being developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results for that condition. |
| CAS Number | 285985-06-0 |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | TGFB2[Homo sapiens] |
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
